CMS Projects Annual Medicare Rx Market Of $181 Bil. In 2015
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency projects that total payments to Medicare Rx plans over fiscal years 2006-2015 will be $1.2 tril. CMS stresses that the new cost projections are consistent with previous estimates, plus two additional years of the drug benefit in action.
You may also be interested in...
Medicare Part D Benefit Pegged At $53.6 Bil. For 2006 By House Panel
The amount matches the estimate in the Administration’s budget request for the first nine months of the Rx drug benefit. A vote on the House Appropriations subcommittee’s mark by the full committee is slated for June 15, but may be rescheduled for June 16.
Medicare Part D Benefit Pegged At $53.6 Bil. For 2006 By House Panel
The amount matches the estimate in the Administration’s budget request for the first nine months of the Rx drug benefit. A vote on the House Appropriations subcommittee’s mark by the full committee is slated for June 15, but may be rescheduled for June 16.
HHS Touts MMA Drug Provisions As Counterweight To High Medicare Costs
E-prescribing, medication therapy management, the availability of generics through Part D, and a focus on drug effectiveness data will bolster Medicare’s fiscal integrity, HHS says. The 2005 Medicare Trustees Report projects that the hospital insurance trust fund will be insolvent in 2020.